Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Robinson

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Kidney International Reports|March 16, 2022
The COVID-19 Pandemic Identifies Significant Global Inequities in Hemodialysis Care in Low and Lower-Middle Income Countries-An ISN/DOPPS SurveyElliot Koranteng Tannor, Brian Bieber, Ryan Aylward, et al.
Annals of Surgical Oncology|May 25, 2021
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
Intensive Care Medicine|June 20, 2015
Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study, Simon Finfer, Dean Chittock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 2, 2021
New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN studyAghilès Hamroun, Luc Frimat, Maurice Laville, et al.
Immunity, Inflammation and Disease|March 3, 2017
Transient Treg depletion enhances therapeutic anti-cancer vaccinationScott A Fisher, Wayne J Aston, Jonathan Chee, et al.
Clinical Kidney Journal|November 28, 2015
Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USABrenda W Gillespie, Hal Morgenstern, Elizabeth Hedgeman, et al.
The Lancet. Oncology|July 8, 2021
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trialMarcia S Brose, Bruce Robinson, Steven I Sherman, et al.
European Journal of Endocrinology|September 6, 2002
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidismAndrea Villablanca, Wassif S Wassif, Thomas Smith, et al.
The Journal of Pathology|December 30, 2014
The genomic landscape of phaeochromocytomaAidan Flynn, Diana Benn, Roderick Clifton-Bligh, et al.
Scientific Reports|January 28, 2016
Activating mutations in CTNNB1 in aldosterone producing adenomasTobias Åkerström, Rajani Maharjan, Holger Sven Willenberg, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Kidney International Reports|March 16, 2022
The COVID-19 Pandemic Identifies Significant Global Inequities in Hemodialysis Care in Low and Lower-Middle Income Countries-An ISN/DOPPS SurveyElliot Koranteng Tannor, Brian Bieber, Ryan Aylward, et al.
Annals of Surgical Oncology|May 25, 2021
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
Intensive Care Medicine|June 20, 2015
Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study, Simon Finfer, Dean Chittock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 2, 2021
New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN studyAghilès Hamroun, Luc Frimat, Maurice Laville, et al.
Immunity, Inflammation and Disease|March 3, 2017
Transient Treg depletion enhances therapeutic anti-cancer vaccinationScott A Fisher, Wayne J Aston, Jonathan Chee, et al.
Clinical Kidney Journal|November 28, 2015
Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USABrenda W Gillespie, Hal Morgenstern, Elizabeth Hedgeman, et al.
The Lancet. Oncology|July 8, 2021
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trialMarcia S Brose, Bruce Robinson, Steven I Sherman, et al.
European Journal of Endocrinology|September 6, 2002
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidismAndrea Villablanca, Wassif S Wassif, Thomas Smith, et al.
The Journal of Pathology|December 30, 2014
The genomic landscape of phaeochromocytomaAidan Flynn, Diana Benn, Roderick Clifton-Bligh, et al.
Scientific Reports|January 28, 2016
Activating mutations in CTNNB1 in aldosterone producing adenomasTobias Åkerström, Rajani Maharjan, Holger Sven Willenberg, et al.
Pageof 17